This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Life Sciences Accounting & Reporting Congress
March 18-20, 2025
Hilton at Penn's LandingPhiladelphia, PA

Jennifer Kyle
Founder and CEO at Condor Software
Speaker

Profile

Jennifer Kyle is the Founder and CEO of Condor Software. A former auditor, Controller, and CPA, Jennifer is on a mission to help biotech companies with their financial processes and provide them with better tools for clinical accruals & forecasting.

Jennifer began her career in accounting as a CPA and auditor for Ernst & Young before transitioning into finance and operations leadership at biotech organizations. She personally solved clinical financial management problems at several biotech organizations and was deeply impacted by family and loved ones at the intersection of life, death, and clinical trials. This inspired her to partner with a CTO to build software that empowers biotech teams to bring more life-saving therapies to market without being held back by billions of dollars lost in obscure data and financial processes.

What keeps Jennifer focused and driven is the promise she made to her father during his extra year of life an immunotherapy gave him for his NSCLC and the promise she gave to a dear friend, Steven, who was able to give life to his daughter, Ainsley, because of a clinical trial. Jennifer works long and hard alongside accountants, finance, clinical, and service providers to help these patients survive and kick cancer. As her father would always say, "where there's a will, there's a way." This is for him, Steven, and everyone out there who beat cancer or is fighting hard to survive.

Jennifer is a licensed CPA in California and resides in San Diego. She graduated from University of South Florida with a Bachelor of Science in Business Management with an emphasis in Economics.

Agenda Sessions

  • Financial Considerations for Clinical Trials

    2:50pm